Escalating anti-inflammatory therapy with tocilizumab in patients with severe COVID-19

Authors: Lipworth, Brian J. ;

Chan, Rory

Source: BMJ

Full text

: https://doi.org/10.1136/bmj.n84

Abstract

Rights

This content is not covered by the Open Government Licence. Please see source record or item for information on rights and permissions.

Cite as

Lipworth, B. & Chan, R. 2021, 'Escalating anti-inflammatory therapy with tocilizumab in patients with severe COVID-19', BMJ, 372, article no: n84. https://doi.org/10.1136/bmj.n84

Downloadable citations

HTML BIB RIS

Identifiers

DOI: https://doi.org/10.1136/bmj.n84

Repository URI: https://discovery.dundee.ac.uk/en/publications/2022dcda-2eef-4449-9e41-92091b4d9e34